14.02.2023 - CAMBRIDGE, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) - Cullinan Oncology, Inc. (Nasdaq: CGEM) and Harbour BioMed (HKEX: 02142) today announced that Cullinan Oncology has entered into an exclusive license with Harbour BioMed for the development and . Seite 1
Cullinan Oncology (CGEM) Licenses US Rights to HBM7008 from Harbour BioMed streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cullinan Oncology (CGEM) Boosts Ownership Stake in its MICA Subsidiary streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.